AmBank Research is positive on IHH’s latest reported results and it has maintained its “buy” call on the stock with a higher fair value of RM6.58 per share. (File pic: IHH Pantai Hospital, KL)
THE losses reported by TMC Life Sciences Bhd
in its latest quarter is a barometer of how some private hospitals had unexpectedly struggled with the effects of the Covid-19 pandemic.
Their business appears to be still an attractive proposition despite the ongoing pandemic with many favourable views from analysts and even with money from other industries pouring into this sector prior to the outbreak.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
